Clinical trial
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
NCT04574635 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 17, 2020
- Completion date
- November 30, 2027
- Enrollment
- 18 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cervical adenosquamous carcinoma, cervical squamous cell carcinoma, not otherwise specified, infiltrating cervical carcinoma, metastatic cervical carcinoma, recurrent cervical carcinoma, stage i cervical cancer figo 2018, stage ia cervical cancer figo 2018, stage ia1 cervical cancer figo 2018, stage ia2 cervical cancer figo 2018, stage ib cervical cancer figo 2018, stage ib1 cervical cancer ajcc v8, stage ib2 cervical cancer figo 2018, stage ib3 cervical cancer figo 2018, stage ii cervical cancer figo 2018, stage iia cervical cancer figo 2018, stage iia1 cervical cancer figo 2018, stage iia2 cervical cancer figo 2018, stage iib cervical cancer figo 2018, stage iii cervical cancer figo 2018, stage iiia cervical cancer figo 2018, stage iiib cervical cancer figo 2018, stage iiic cervical cancer figo 2018, stage iiic1 cervical cancer figo 2018, stage iiic2 cervical cancer figo 2018, stage iv cervical cancer figo 2018, stage iva cervical cancer figo 2018, stage ivb cervical cancer figo 2018